Injectafer denied for failing step therapy by Blue Cross Blue Shield?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
HFrEF / HFmrEF with iron deficiency (ferritin <100 OR 100-299 with TSAT <20%) to improve symptoms and reduce HF hospitalizations.
What works in the appeal
ESC 2021 HF Guidelines (McDonagh Eur Heart J 2021;42:3599) — Class IIa for IV FCM in HFrEF iron def. Ferritin <100 OR 100-299 + TSAT <20% IS iron deficient in HF context. FAIR-HF NEJM 2009 + CONFIRM-HF Eur Heart J 2015 + AFFIRM-AHF Lancet 2020 + HEART-FID NEJM 2023. Oral iron does NOT improve HFrEF outcomes (IRONOUT-HF JAMA 2017 negative).
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →